BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22151825)

  • 21. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
    Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
    Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma.
    Pontisso P; Quarta S; Caberlotto C; Beneduce L; Marino M; Bernardinello E; Tono N; Fassina G; Cavalletto L; Gatta A; Chemello L
    Int J Cancer; 2006 Aug; 119(4):735-40. PubMed ID: 16550605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of Ki67 Expression for Patients with Surgically Resected Hepatocellular Carcinoma: Perspectives from a High Incidence Area.
    Bai K; Cao Y; Huang Q; Jiang Y; Lv L
    Clin Lab; 2017 Feb; 63(2):355-364. PubMed ID: 28182353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- and long-term prediction of hepatocellular carcinoma among cirrhotic patients.
    Gil-Gómez A; Rojas Á; Liu CH; Gallego-Duran R; Muñoz-Hernandez R; Fassina G; Pontisso P; Ampuero J; Romero-Gómez M
    World J Gastroenterol; 2021 Dec; 27(48):8343-8356. PubMed ID: 35068873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
    Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
    Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
    Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
    Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
    Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High cytoplasmic expression of Krüppel-like factor 4 is an independent prognostic factor of better survival in hepatocellular carcinoma.
    Hsu HT; Wu PR; Chen CJ; Hsu LS; Yeh CM; Hsing MT; Chiang YS; Lai MT; Yeh KT
    Int J Mol Sci; 2014 Jun; 15(6):9894-906. PubMed ID: 24897024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Squamous cell carcinoma antigen 1 and 2 mRNA and a new variant expressed in hepatocellular carcinoma.
    Li S; Gao Y; Yang B; Liang Z; Wang Y; Zhai D; Jing L; Liu T; Wang F; DU Z; Wang Y
    Neoplasma; 2014; 61(6):718-23. PubMed ID: 25150316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma.
    Wu PC; Lau VK; Fang JW; Lai VC; Lai CL; Lau JY
    Liver; 1999 Oct; 19(5):444-51. PubMed ID: 10533805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
    Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
    Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth index, assessed with Ki-67 and ssDNA labeling; a significant prognosticator for patients undergoing curative resection for hepatocellular carcinoma.
    Morinaga S; Ishiwa N; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
    J Surg Oncol; 2005 Dec; 92(4):331-6. PubMed ID: 16299800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-level expression of periostin is closely related to metastatic potential and poor prognosis of hepatocellular carcinoma.
    Lv Y; Wang W; Jia WD; Sun QK; Li JS; Ma JL; Liu WB; Zhou HC; Ge YS; Yu JH; Xia HH; Xu GL
    Med Oncol; 2013 Mar; 30(1):385. PubMed ID: 23275141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA fragmentation and cell proliferation correlated with tumor grade in patients with hepatocellular carcinoma.
    Kalogeraki A; Garbagnati F; Santinami M; Zoras O
    Cancer; 2002 Oct; 96(5):301-5. PubMed ID: 12378598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients.
    Guzman G; Alagiozian-Angelova V; Layden-Almer JE; Layden TJ; Testa G; Benedetti E; Kajdacsy-Balla A; Cotler SJ
    Mod Pathol; 2005 Nov; 18(11):1498-503. PubMed ID: 16007066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome.
    Xiang ZL; Zeng ZC; Fan J; Tang ZY; He J; Zeng HY; Chang JY
    Mol Biol Rep; 2012 Feb; 39(2):2021-9. PubMed ID: 21647551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular Carcinoma Score and Subclassification Into Aggressive Subtypes Using Immunohistochemical Expression of p53, β-Catenin, CD133, and Ki-67.
    Abdou AG; Holah NS; Elazab DS; El-Gendy WG; Badr MT; Al-Sharaky DR
    Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):20-33. PubMed ID: 32287076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels.
    Sheng X; Du X; Zhang X; Li D; Lu C; Li Q; Ma Z; Song Q; Wang C
    Croat Med J; 2009 Oct; 50(5):455-64. PubMed ID: 19839069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.
    Aigelsreiter A; Ress AL; Bettermann K; Schauer S; Koller K; Eisner F; Kiesslich T; Stojakovic T; Samonigg H; Kornprat P; Lackner C; Haybaeck J; Pichler M
    Br J Cancer; 2013 May; 108(9):1830-7. PubMed ID: 23591196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma.
    Wang R; Yu Z; Chen F; Liao C; Wang Q; Huang X
    Hum Pathol; 2018 Mar; 73():114-121. PubMed ID: 29288040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.